July 29, 2022
Video
Expert panelists consider later-line treatment options for a patient with recurrent hepatocellular carcinoma.
July 29, 2022
Video
Comprehensive insight on several clinical trials analyzing frontline combination therapies for patients with unresectable hepatocellular carcinoma.
July 29, 2022
Video
In the setting of unresectable hepatocellular carcinoma, experts consider the role of frontline atezolizumab + bevacizumab given data from IMbrave150.
July 22, 2022
Video
A brief review of treatment options for patients with Child-Pugh B grade metastatic hepatocellular carcinoma.
July 22, 2022
Video
Panelists consider the adverse event profile of frontline TKI therapy in patients with metastatic HCC and review options for dosing and dose reduction.
July 15, 2022
Video
Comprehensive discussion on the PFS subgroup data from REFLECT, which compared frontline lenvatinib and sorafenib therapy in metastatic HCC.